New data shows that morbidly obese people with Type 2 diabetes that undergo bariatric surgery fully recover the costs of the surgery in two to three years and experience a significant reduction in diabetes diagnostics claims and diabetes medication claims after the surgery.
The study was conducted by Washington University School of Medicine in St. Louis, Université du Québec à Montréal (UQAM), and Analysis Group, Inc. Many people (more…)
Two different studies have suggested that bariatric surgery for patients with type 2 diabetes is cost–effective.
The first study‚ involving administrative claims data of 2‚235 patients with diabetes aged 18 to 64 years‚ looked at the main outcomes of overall healthcare costs and use of diabetes medications. Compared with the baseline annual cost of $6‚376 per patient, the first–year total annual healthcare costs increased 9.7 (more…)
A new study shows diabetics undergoing bariatric surgery typically no longer need to take insulin and other medications controlling blood sugar, Dow Jones Newswires reports.
Nearly three-quarters of obese patients diagnosed with type 2 were off the medicine within six month of the weigh-loss surgery, according to the research carried out at Johns Hopkins University and published in the Archives of Surgery.
In light of the findings, (more…)
Type 2 diabetes patients who underwent bariatric surgery appear to require significantly less medication and incur considerably lower health costs, says a report published in this month’s issue of Archives of Surgery , a JAMA/Archives journal. Bariatric surgery is a surgical procedure on the stomach and/or intestines to help extremely obese people lose weight – it is an option for patients with a BMI ( body (more…)